APM
Price:
$8.2601
Market Cap:
$764.69K
Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule, which is in phase 1 clinical trial for the treatment of bacterial infections, such as staphylococcus aureus, mycobacterium tuberculosis, and pseudomonas aeruginosa; and RPIDD, a liquid biopsy rapid pathogen diagnostic which is in preclinical trial to treat pathogen molecular diagnostics. The c...[Read more]
Industry
Biotechnology
IPO Date
2018-12-18
Stock Exchange
NASDAQ
Ticker
APM
According to Aptorum Group Limited’s latest financial reports and current stock price. The company's current ROE is -5.94%. This represents a change of 130.43% compared to the average of -2.58% of the last 4 quarters.
The mean historical ROE of Aptorum Group Limited over the last ten years is -39.61%. The current -5.94% ROE has changed -85.00% with respect to the historical average. Over the past ten years (40 quarters), APM's ROE was at its highest in in the December 2020 quarter at 31.72%. The ROE was at its lowest in in the December 2019 quarter at -58.66%.
Average
-39.61%
Median
-20.19%
Minimum
-114.22%
Maximum
16.89%
Discovering the peaks and valleys of Aptorum Group Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 431.84%
Maximum Annual ROE = 16.89%
Minimum Annual Increase = -728.09%
Minimum Annual ROE = -114.22%
| Year | ROE | Change |
|---|---|---|
| 2025 | -5.89% | -70.85% |
| 2024 | -20.19% | 77.61% |
| 2023 | -11.37% | -81.77% |
| 2022 | -62.37% | -41.22% |
| 2021 | -106.10% | -728.09% |
| 2020 | 16.89% | -114.79% |
| 2019 | -114.22% | 155.00% |
| 2018 | -44.79% | 431.84% |
The current ROE of Aptorum Group Limited (APM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-12.48%
5-year avg
-41.19%
10-year avg
-39.61%
Aptorum Group Limited’s ROE is greater than Marker Therapeutics, Inc. (-73.29%), greater than Mustang Bio, Inc. (-34.23%), greater than Cingulate Inc. (-365.16%), greater than Cellectar Biosciences, Inc. (-264.79%), greater than Immuron Limited (-43.95%), less than AEON Biopharma, Inc. (223.66%), greater than Bolt Biotherapeutics, Inc. (-100.90%), greater than Cocrystal Pharma, Inc. (-150.61%), less than Evogene Ltd. (937.72%), less than Lyra Therapeutics, Inc. (1.21%),
| Company | ROE | Market cap |
|---|---|---|
| -73.29% | $12.31M | |
| -34.23% | $4.52M | |
| -365.16% | $27.69M | |
| -264.79% | $8.04M | |
| -43.95% | $7.09M | |
| 223.66% | $7.34M | |
| -100.90% | $7.59M | |
| -150.61% | $14.06M | |
| 937.72% | $5.44M | |
| 1.21% | $709.95K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aptorum Group Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aptorum Group Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Aptorum Group Limited's ROE?
How is the ROE calculated for Aptorum Group Limited (APM)?
What is the highest ROE for Aptorum Group Limited (APM)?
What is the 3-year average ROE for Aptorum Group Limited (APM)?
What is the 5-year average ROE for Aptorum Group Limited (APM)?
How does the current ROE for Aptorum Group Limited (APM) compare to its historical average?